In response to these signals, tumor-resident Tregs undergo transcriptional and epigenetic remodeling, often acquiring a tissue-adapted phenotype marked by high expression of immune checkpoints (e.g., CTLA-4, TIGIT, PD-1) and enhanced suppressive capacity. This evidence concerns the gene CTLA4 and neoplasm.